Industry Funding and Author Conflicts: How to Read the Disclosure Section

A study’s disclosure section lists who funded the research, what role that funder played, and whether the authors have financial ties to it. Reading it well means recording those facts without deciding, on that basis alone, that the study is trustworthy or worthless. This guide shows exactly where to find each part of the disclosure and what it does and doesn’t tell you.

What Does a Study’s Disclosure Section Actually Tell You?

A disclosure statement is not a verdict. Industry funding does not automatically mean a study is biased, and an independent grant does not automatically mean a study is flawless. What the disclosure section gives you is context — information you weigh alongside a study’s design, sample size, and results, not information that replaces that evaluation. As How to Read a Clinical Study explains, funding and conflict-of-interest disclosures are one of seven standard sections in a typical study, sitting alongside methods and results rather than above them.

The International Committee of Medical Journal Editors (ICMJE), whose recommendations most medical and health journals follow, states that public trust in published research depends on how transparently a study’s relationships and activities are handled. That transparency only helps you if you know what to look for and how to record it.

What Do Sponsor, Conflict of Interest, and Data Access Actually Mean?

Sponsor/Funder — The organization that paid for the study, supplied the product being tested, or provided a research grant. This can be a government agency, a university, a non-profit, or a manufacturer.
Financial Conflict of Interest — A financial relationship between an author and the study’s sponsor, such as employment, consulting fees, stock ownership, patents, or speaking fees.
Non-Financial Conflict of Interest — A non-monetary interest that could still influence a researcher’s objectivity, such as career advancement tied to a positive result or personal advocacy for a treatment.
Data Access Statement — A statement describing whether study authors had full access to the raw data, or only to data selected or processed by the sponsor.
Publication Control — Language describing whether the sponsor could review, edit, delay, or block publication of results before they reached a journal.

What Can a Disclosure Statement Tell You — and What Can’t It?

A single disclosure paragraph usually bundles several kinds of information together. Separating them out helps you record each one accurately instead of treating “the disclosure” as one undifferentiated fact.

Funding source. Tells you who paid for the study. It does not tell you whether that funder influenced the design, analysis, or conclusions — that requires the next item.
Sponsor role statement. Tells you whether the funder was involved in designing the study, collecting or analyzing data, writing the manuscript, or deciding whether to submit it for publication. ICMJE guidance calls for this to be stated explicitly, with the sponsor’s role in each stage described “if any.” It does not tell you the size or direction of any bias that involvement may have introduced.
Author financial relationships. Tells you whether individual researchers, separate from the study’s funding, have consulting arrangements, equity, patents, or other financial ties to the sponsor or a competing company. It does not tell you whether those ties affected this particular study’s results.
Data access and publication control. Tells you whether authors could see and analyze all the raw data themselves, and whether they kept the right to publish regardless of what the sponsor preferred. ICMJE guidance states that authors should avoid agreements limiting their access to the full data set or their ability to analyze, interpret, and publish independently. This is the item most often missing from casual reporting on a study, and it’s frequently the most informative one.

How Do You Find and Record Funding and Conflict Information in a Study?

Use this sequence when reading a published study or its listing on a database like PubMed or ClinicalTrials.gov. It applies to supplement research the same way it applies to drug trials.

Locate the disclosure section. It’s typically labeled “Conflicts of Interest,” “Author Disclosures,” “Funding,” “Declaration of Interests,” or “Role of the Funding Source,” and sits near the end of the article, close to the references or acknowledgments.
Write down the funding source by name. Note whether it’s a government body, university, non-profit foundation, ingredient supplier, or product manufacturer. If the paper names no funder at all, record that as its own data point — it’s a gap, not a neutral finding.
Look specifically for a sponsor-role sentence. Search for language about design, data collection, analysis, interpretation, manuscript preparation, or the decision to submit for publication. If the statement only names the funder without describing a role, record it as “funding disclosed, role not described.”
Check author affiliations and the conflict-of-interest list separately from the funding line. These often appear in a different sentence or a separate author-contribution section. Note any consulting fees, employment, equity, or patents listed for individual authors.
Look for a data access statement. Some journals require a specific sentence such as “the authors had full access to all study data.” If it’s absent, record access as unknown rather than assuming it was granted or restricted.
Look for publication control language. This is the least commonly stated item and the easiest to miss. Some disclosures explicitly state the sponsor had no role in the decision to publish; others say nothing at all.
Record what’s present and what’s missing, separately. A complete disclosure and a thin one both give you real information — just different kinds.

How Do You Weigh What You Find Without Jumping to a Conclusion?

The goal at this stage is documentation, not conclusion. Note four fields for each study: funding source, sponsor’s stated role (or “not stated”), authors’ financial ties (or “none disclosed”), and data access or publication control language (or “not addressed”). Recording “not stated” is a legitimate, useful entry — it’s an accurate record of what the paper does and doesn’t tell you, not a failure to find something.

From there, a few simple if-then rules keep you from over- or under-reacting to any single line:

If a study names a manufacturer as funder but fully describes the sponsor’s role, the authors’ data access, and independent publication rights, then treat that as a relatively complete disclosure and weigh it alongside study design and sample size, not instead of them.
If a study names a funder but describes no sponsor role, no data access statement, and no publication-control language, then treat the study’s independence as unverified rather than assuming either bias or neutrality.
If a study reports no funding source at all, then record that as a disclosure gap and check the journal’s own requirements before assuming the research was unfunded.
If several studies on the same question show a mix of funding sources and reach similar conclusions, that pattern of replication tells you more than any single disclosure statement does — a point covered in more depth in Research Funding, Conflicts of Interest, and Study Independence.

What Can’t the Disclosure Section Tell You?

A disclosure statement documents relationships; it does not measure their effect on a specific result. Two studies with identical funding disclosures can differ enormously in study quality, and a well-disclosed, sponsor-involved study can still be well-designed and honestly reported. Disclosure completeness also varies by journal — some require detailed sponsor-role statements, others accept a single sentence naming the funder, and a short disclosure may reflect a journal’s minimal requirements rather than anything the authors withheld.

None of this is a reason to skip the disclosure section. It’s a reason to read it as one input alongside study design, sample size, and results — the same combined approach described in Evaluating Evidence Quality — rather than a final answer on its own.

Frequently Asked Questions

Does industry funding automatically make a study unreliable?

No. Industry funding is one factor to record, not a disqualifier. A study’s design, sample size, and whether its findings have been replicated by independently funded research matter more to reliability than the funding source alone.

What’s the difference between a financial and a non-financial conflict of interest?

A financial conflict involves money — consulting fees, stock, patents, or employment tied to the sponsor. A non-financial conflict involves other incentives, such as career advancement or personal advocacy for a treatment, that could still affect how a researcher interprets results.

Where exactly is the disclosure section located in a published study?

It’s usually near the end of the article, close to the references or acknowledgments, under a heading like “Conflicts of Interest,” “Author Disclosures,” or “Role of the Funding Source.” Database listings on PubMed or ClinicalTrials.gov sometimes summarize it separately from the full text.

What does it mean if a study doesn’t include a data access statement?

It means that information simply isn’t available to you as a reader — not that access was necessarily restricted. Record it as “not addressed” and look for whether other studies on the same topic include a clearer statement.

Can a sponsor block a study from being published?

ICMJE guidance states that authors should avoid agreements that let a sponsor interfere with their ability to analyze, interpret, and publish results independently. Whether that guidance was followed in a specific case is exactly what publication-control language in the disclosure section is meant to show.

Sources

Disclosure requirements described in this guide are based on the International Committee of Medical Journal Editors’ recommendations on author responsibilities and conflicts of interest, and on the funding and sponsor-role reporting items required by the CONSORT and SPIRIT reporting guidelines for trial reports and protocols.

This guide explains how to read the funding and conflict-of-interest section of a published study. It does not evaluate any specific supplement or product, diagnose any condition, or state whether a product is safe or effective. If you’re weighing a health decision, talk with a qualified healthcare provider. If you are experiencing a medical emergency, call your local emergency services immediately.

By ClinicalStudyConnect.com Research Desk | Last updated September 11, 2026